A pilot clinical trial has found that low-dose lithium tablets might help slow verbal decline among seniors with mild ...
An exploratory clinical trial from the University of Pittsburgh has found that low-dose oral lithium may help slow the decline of verbal memory in older adults with mild cognitive impairment.
Lithium—a decades-old treatment for bipolar disorder—may hold potential neuroprotective benefits beyond mood stabilization.
A clinical trial suggests that low-dose lithium may slow the decline of verbal memory in older adults with mild cognitive impairment and amyloid-beta.
In collaboration with Massachusetts General Hospital as the clinical trial site, Alzamend is investigating the distinctive characteristics of AL001. Alzamend Neuro AL001 (LiProSal) is a novel, ...
Licensed as a psychiatric nurse practitioner more than 20 years ago, I thought I’d never need or want to prescribe lithium. Old school, I thought. A 1950s drug; we have much better now. It’s true, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results